- Home
- MGRX vs DOMH Comparison
MGRX vs DOMH Comparison
Compare MGRX & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRX
- DOMH
- Stock Information
- Founded
- MGRX 2021
- DOMH 1967
- Country
- MGRX United States
- DOMH United States
- Employees
- MGRX N/A
- DOMH N/A
- Industry
- MGRX Computer Software: Prepackaged Software
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- MGRX Technology
- DOMH Health Care
- Exchange
- MGRX Nasdaq
- DOMH Nasdaq
- Market Cap
- MGRX 6.3M
- DOMH 7.3M
- IPO Year
- MGRX 2023
- DOMH N/A
- Fundamental
- Price
- MGRX $2.61
- DOMH $1.23
- Analyst Decision
- MGRX
- DOMH
- Analyst Count
- MGRX 0
- DOMH 0
- Target Price
- MGRX N/A
- DOMH N/A
- AVG Volume (30 Days)
- MGRX 96.9K
- DOMH 68.6K
- Earning Date
- MGRX 11-14-2024
- DOMH 11-08-2024
- Dividend Yield
- MGRX N/A
- DOMH N/A
- EPS Growth
- MGRX N/A
- DOMH N/A
- EPS
- MGRX N/A
- DOMH N/A
- Revenue
- MGRX $755,000.00
- DOMH $12,589,000.00
- Revenue This Year
- MGRX N/A
- DOMH N/A
- Revenue Next Year
- MGRX N/A
- DOMH N/A
- P/E Ratio
- MGRX N/A
- DOMH N/A
- Revenue Growth
- MGRX 52.20
- DOMH 1117.50
- 52 Week Low
- MGRX $2.07
- DOMH $0.83
- 52 Week High
- MGRX $16.80
- DOMH $3.20
- Technical
- Relative Strength Index (RSI)
- MGRX 52.13
- DOMH 49.20
- Support Level
- MGRX $2.07
- DOMH $1.00
- Resistance Level
- MGRX $2.77
- DOMH $1.29
- Average True Range (ATR)
- MGRX 0.17
- DOMH 0.14
- MACD
- MGRX 0.01
- DOMH 0.02
- Stochastic Oscillator
- MGRX 77.70
- DOMH 86.96
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.